{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/hypothyroidism/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"42799fb8-7252-541e-9af1-27ebc28710b7","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field 08f6dc2f-4db6-4f99-87b8-615ac7540045 --><h2>How should I assess a person with suspected hypothyroidism?</h2><!-- end field 08f6dc2f-4db6-4f99-87b8-615ac7540045 -->","summary":"","htmlStringContent":"<!-- begin item bbba6cdf-518d-425c-9bff-c04ed18034a2 --><!-- begin field 8fd9ba72-a42f-40dc-9572-f47e83aa1350 --><p><strong>If a diagnosis of hypothyroidism is <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/diagnosis/diagnosis/\">suspected</a>, assess the person and arrange investigations in primary care.</strong></p><ul><li><strong>Ask about:</strong><ul><li>Typical <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/diagnosis/diagnosis/\">symptoms</a> of hypothyroidism.</li><li>Current or recent pregnancy. See the sections on <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/management/preconception-or-pregnant/#management\">Scenario: Preconception or pregnant</a> and <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/management/postpartum/\">Scenario: Postpartum</a> for more information.</li><li>Any current or recent <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/diagnosis/assessment/#interpreting-thyroid-function-tests\">non-thyroidal illness</a>.<ul><li>If suspected, do not check thyroid function tests (TFTs) during acute illness unless it is felt that symptoms may be due to thyroid dysfunction, as acute non-thyroidal illness is likely to affect thyroid function test (TFT) results.</li></ul></li><li>Any <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/background-information/causes/\">drug treatment</a> such as amiodarone, lithium, or over-the-counter <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/diagnosis/assessment/#interpreting-thyroid-function-tests\">supplements</a> such as biotin that may affect TFTs.</li><li>Any other risk factors associated with hypothyroidism, such as:<ul><li>Family history of thyroid or autoimmune disease; personal or family history of hypothalamic-pituitary disease.</li><li>Personal history of autoimmune disorders, such as Addison’s disease, alopecia areata, pernicious anaemia, coeliac disease, type 1 diabetes mellitus, and vitiligo. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/addisons-disease/\">Addison&#39;s disease</a>, <a class=\"topic-reference external-reference\" href=\"/topics/alopecia-areata/\">Alopecia areata</a>, <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-b12-folate-deficiency/\">Anaemia - B12 and folate deficiency</a>, <a class=\"topic-reference external-reference\" href=\"/topics/coeliac-disease/\">coeliac disease</a>, <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-1/\">Diabetes - type 1</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/vitiligo/\">Vitiligo</a> for more information.</li><li>History of Turner or Down's syndrome.</li><li>Previous radiotherapy to the head and neck, radioiodine treatment, or thyroid or neck surgery.</li><li>History of iodine deficiency.</li></ul></li><li>Any possible causes of <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/background-information/causes/\">secondary hypothyroidism</a>, such as history of brain or metastatic cancer; infiltrative disease; head trauma; surgery, radiotherapy or disease affecting the pituitary gland or hypothalamus.</li></ul></li><li><strong>Examine the person for:</strong><ul><li>Possible <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/diagnosis/diagnosis/\">signs</a> or <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/background-information/complications/\">complications</a> of hypothyroidism.</li><li>Thyroid enlargement (a goitre) and/or thyroid nodules.<ul><li>A hard and irregular goitre or nodule may indicate malignancy. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/head-neck-cancers-recognition-referral/\">Head and neck cancers - recognition and referral</a> for more information on urgent management.</li><li>Thyroid pain may indicate <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/background-information/causes/\">subacute thyroiditis</a>.</li></ul></li><li>Signs of other autoimmune disease such as Addison’s disease, alopecia areata, pernicious anaemia, coeliac disease, type 1 diabetes mellitus, and vitiligo. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/addisons-disease/\">Addison&#39;s disease</a>, <a class=\"topic-reference external-reference\" href=\"/topics/alopecia-areata/\">Alopecia areata</a>, <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-b12-folate-deficiency/\">Anaemia - B12 and folate deficiency</a>, <a class=\"topic-reference external-reference\" href=\"/topics/coeliac-disease/\">coeliac disease</a>, <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-1/\">Diabetes - type 1</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/vitiligo/\">Vitiligo</a> for more information.</li></ul></li><li><strong>Check the serum thyroid-stimulating hormone (TSH) level, using clinical judgement to <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/diagnosis/assessment/#interpreting-thyroid-function-tests\">interpret thryoid function test</a> (TFT) results,</strong> especially if TFTs do not match the clinical presentation.<ul><li>Consider arranging repeat TFTs depending on clinical judgement, if indicated.</li><li>If symptoms worsen or new symptoms develop, consider rechecking TFTs at least six weeks after the last sample.</li></ul></li><li><strong>If the TSH level is above the normal reference range, the free thyroxine (FT4) level should be measured in the same sample.</strong><ul><li>Suspect a diagnosis of <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/background-information/definition/\">primary hypothyroidism</a> if TSH levels are above the normal reference range (usually above 10 mU/L) and FT4 is below the normal reference range.</li><li>Suspect a diagnosis of <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/background-information/definition/\">subclinical hypothyroidism</a> if TSH levels are above the normal reference range and FT4 is within the normal reference range.<ul><li>In non-pregnant people, repeat TFTs 3–6 months after the initial result to exclude <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/diagnosis/assessment/#interpreting-thyroid-function-tests\">other causes</a> of a transiently raised TSH and to confirm the diagnosis.</li></ul></li><li>Suspect hypothyroidism in <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/background-information/definition/\">pregnancy</a> if TSH levels are elevated (using trimester-specific reference ranges) which may or may not be associated with a FT4 level below the trimester-specific reference range.</li><li>Suspect the hypothyroid phase of <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/background-information/prognosis/\">postpartum thyroiditis</a> (PPT) if TSH is raised within a year of giving birth.</li><li>Suspect a diagnosis of <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/background-information/definition/\">secondary hypothyroidism</a> if clinical features are suggestive and TSH levels are inappropriately low (may be normal), but FT4 is below the normal reference range. Note: check both TSH and FT4 levels in these cases when arranging initial tests.</li><li>Suspect an <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/diagnosis/differential-diagnosis/\">alternative diagnosis</a> if TFTs are within the normal euthyroid range.</li><li>Note: do <em>not</em> routinely measure total tri-iodothyronine (T3), total thyroxine (T4), or free tri-iodothyronine (FT3) levels in primary care.</li></ul></li><li><strong>Consider checking additional blood tests if primary hypothyroidism is suspected:</strong><ul><li>Full blood count (FBC) and serum B12 level — to assess for possible associated pernicious anaemia. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-b12-folate-deficiency/\">Anaemia - B12 and folate deficiency</a> for more information.</li><li>Glycated haemoglobin (HbA1c) — to assess for associated type 1 diabetes mellitus. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-1/\">Diabetes - type 1</a> for more information.</li><li>Coeliac serology — to assess for coeliac disease if a diagnosis of autoimmune thyroid disease is suspected. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/coeliac-disease/\">Coeliac disease</a> for more information.</li><li>Serum lipids — to assess for associated dyslipidaemia. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/cvd-risk-assessment-management/\">CVD risk assessment and management</a> and <a class=\"topic-reference external-reference\" href=\"/topics/lipid-modification-cvd-prevention/\">Lipid modification - CVD prevention</a> for more information.</li></ul></li><li><strong>Consider checking serum thyroid peroxidase antibodies (TPOAb) if:</strong><ul><li>Autoimmune thyroid disease is suspected — raised levels may suggest autoimmune primary hypothyroidism.<ul><li>Do not arrange repeat testing of TPOAb.</li></ul></li><li>A diagnosis of subclinical hypothyroidism is suspected — positive TPOAb can predict progression to overt hypothyroidism.<ul><li>Do not arrange repeat testing of TPOAb.</li></ul></li><li>The person is pregnant — be aware that after the first trimester, thyroid autoantibodies may be negative due to immune suppression in pregnancy.</li></ul></li><li><strong>Arrange an ultrasound of the neck to image palpable thyroid enlargement or focal nodularity</strong> in adults with normal thyroid function if malignancy is suspected. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/neck-lump/\">Neck lump</a> for more information.</li></ul><!-- end field 8fd9ba72-a42f-40dc-9572-f47e83aa1350 --><!-- end item bbba6cdf-518d-425c-9bff-c04ed18034a2 -->","topic":{"id":"f1d76bc1-c8dd-515b-a709-48c70c829658","topicId":"ebfc5032-6653-4b11-895c-5080f933e861","topicName":"Hypothyroidism","slug":"hypothyroidism","lastRevised":"Last revised in August 2020","chapters":[{"id":"cf0a606b-f582-5671-a84d-a1a3a12b7180","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"795eb9d9-4e15-51f6-81f4-7cc1b69ca74e","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"a8d7a846-dfa6-5db5-ba95-fb161fd48c6e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"d8567cc1-0642-5e9e-ad6c-8ca4abf5fa6e","slug":"changes","fullItemName":"Changes"},{"id":"c5e99cd1-e0c7-5efd-84bb-15bac6122b1d","slug":"update","fullItemName":"Update"}]},{"id":"2b8464ae-3182-517a-85be-6acc656616c5","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"17d5ebf3-bdca-50d2-a4f5-245d191f4973","slug":"goals","fullItemName":"Goals"},{"id":"9162c6a3-edc4-5319-9418-04b2cb656ce6","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2ae5c1d9-638e-52fa-b738-9561cd11b0ab","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7fec82ae-e144-56a7-b1e8-8744c35e227e","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"610f052f-83a2-5b06-b5e6-4aa272ef73a6","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a578bde3-0d84-54f7-814d-18ed38e6038a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"66bb9b4f-4de2-5da7-aba1-ec9bff4b2454","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"4b8f382f-673d-5804-8291-438e21e32790","slug":"definition","fullItemName":"Definition"},{"id":"ef0d96cd-207c-5814-93cf-c96870e2251d","slug":"causes","fullItemName":"Causes"},{"id":"09adb285-1d01-592a-9443-295b45c7d78b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"9bfb88d8-8d33-53a3-8d0e-1b202457fb2e","slug":"complications","fullItemName":"Complications"},{"id":"5ff1ef9f-bb77-5feb-bd5a-12d7b43cca9d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"cfe582c4-479a-5d44-b893-ac46a1a80b29","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6884c3db-6165-566b-a4ca-3e933de77714","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"42799fb8-7252-541e-9af1-27ebc28710b7","slug":"assessment","fullItemName":"Assessment"},{"id":"e850b740-b6cf-55a7-aed8-7372b7f13b05","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"d817ab4c-e7a3-582a-94fa-fcffd9c2d4f6","slug":"screening","fullItemName":"Screening"}]},{"id":"b377a2c4-68d7-573f-912f-123b99d0aba1","fullItemName":"Management","slug":"management","subChapters":[{"id":"daacd844-c78f-5626-a2ea-93077f98f729","slug":"overt-hypothyroidism-non-pregnant","fullItemName":"Scenario: Overt hypothyroidism (non-pregnant)"},{"id":"e358d249-a2f3-5a06-b301-2119af9ae164","slug":"subclinical-hypothyroidism-non-pregnant","fullItemName":"Scenario: Subclinical hypothyroidism (non-pregnant)"},{"id":"9e4d552e-5fb3-571b-b14a-fec340b943f0","slug":"preconception-or-pregnant","fullItemName":"Scenario: Preconception or pregnant"},{"id":"611f3939-9d39-5545-b225-f9b33fdb095e","slug":"postpartum","fullItemName":"Scenario: Postpartum"}]},{"id":"7b2d6d51-4029-5c06-8789-30e0056076fa","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"ee5ac1fb-6ba7-5e52-9861-d62637c03bf0","slug":"levothyroxine","fullItemName":"Levothyroxine"}]},{"id":"2aaf1754-ba79-5b47-b2a5-74fe8f6af4da","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"7669c894-3a85-55c7-b689-cb4b710a838a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"840d7de5-8c31-5696-9de6-c80ce1bbfec7","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"299c20bf-2a22-5681-99ad-5f02f1395969","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"dd3df39b-4a5c-5416-af8d-dcdbf46bd255","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a88d4431-778a-5793-9557-9f806339a95b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"1987302d-f600-55e0-a528-d3486c49048e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a49e5d2f-75e4-5219-a4d6-fd4a5595a776","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"cfe582c4-479a-5d44-b893-ac46a1a80b29","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"122af477-de41-5f23-8a10-01bd0ec8dd5b","slug":"interpreting-thyroid-function-tests","fullItemName":"Interpreting thyroid function tests","depth":3,"htmlHeader":"<!-- begin field ff7af652-3a0d-457d-8fa6-0dde9384f8aa --><h3>Interpreting thyroid function tests</h3><!-- end field ff7af652-3a0d-457d-8fa6-0dde9384f8aa -->","summary":null,"htmlStringContent":"<!-- begin item 69c94d1b-7be4-442d-a0d6-c9f6342e3f8d --><!-- begin field bb8b92e7-1d88-4eeb-b444-cbe49cccf2f9 --><p><strong>Be aware that thyroid function tests (TFTs) may produce misleading results in certain clinical situations, and clinical judgement should be used when interpreting results </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Chaker, 2017</a>]<strong>.</strong></p><ul><li>Following treatment for hyperthyroidism — recovery of previously suppressed thyroid-stimulating hormone (TSH) can be delayed. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hyperthyroidism/\">Hyperthyroidism</a> for more information.</li><li>Following initiation of levothyroxine (LT4) therapy. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/management/overt-hypothyroidism-non-pregnant/#management\">Scenario: Overt hypothyroidism (non-pregnant)</a> in <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/management/\">Management</a> for more information.</li><li>Non-adherence with LT4 therapy — additional doses in the days before blood monitoring can produce raised TSH and raised free thyroxine (FT4).</li><li>Timing of blood tests — if LT4 therapy is taken shortly before blood sampling, a high TSH with normal or high-normal FT4 may result.</li><li>Diurnal variation — the normal nocturnal peak in TSH may be delayed in night shift workers, those with irregular sleeping patterns, after vigorous exercise, and in mood disorders such as depression.</li><li>Non-thyroidal illness ('sick euthyroid syndrome') – a wide range of acute or chronic non-thyroidal conditions, starvation, and trauma can lead to abnormal TFTs which are not due to true dysfunction of the hypothalamic-pituitary-thyroid (HPT) axis.<ul><li>TSH can be normal or low, then becomes high during recovery from acute illness. FT4 can be normal, low, or high. Free tri-iodothyronine (FT3) is usually low due to reduced conversion of thyroxine (T4) to tri-iodothyronine (T3).</li></ul></li><li>Adrenal insufficiency — may be associated with elevated TSH levels that reverse with glucocorticoid replacement. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/addisons-disease/\">Addison&#39;s disease</a> for more information.</li><li>Obesity — may affect the HPT axis and serum TSH can become raised in overweight or obese people, which may falsely suggest subclinical hypothyroidism.</li><li>Age — the upper limit of TSH reference ranges increases with age in adults. Mild TSH elevation (4.0–7.0 mU/L) may be a normal physiological adaption to ageing.</li><li>Drugs — a wide range of drugs may interfere with TSH secretion; production, secretion and transport of thyroid hormones; or absorption of T4 from the gut.<ul><li>Biotin-containing supplements (bought over-the-counter) may interfere with hormone assays and cause increased TSH but normal or increased FT4.</li><li>Kelp-containing supplements may contain excess iodine.</li><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/prescribing-information/levothyroxine/\">Levothyroxine</a> in <a class=\"topic-reference internal-reference\" href=\"/topics/hypothyroidism/prescribing-information/\">Prescribing information</a> for more information on potential drug interactions with LT4 therapy.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Association for Clinical Biochemisty, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Weetman, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Pearce, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Chaker, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Bekkering, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">McNally, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">NICE, 2019</a>]</p><!-- end field bb8b92e7-1d88-4eeb-b444-cbe49cccf2f9 --><!-- end item 69c94d1b-7be4-442d-a0d6-c9f6342e3f8d -->","subChapters":[]},{"id":"acf236a9-9cbe-5897-bd25-ead49390c8e1","slug":"basis-for-recommendation-7b3","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field ac5e01d0-4f0b-4e76-8917-5b3fabcfc4f5 --><h3>Basis for recommendation</h3><!-- end field ac5e01d0-4f0b-4e76-8917-5b3fabcfc4f5 -->","summary":null,"htmlStringContent":"<!-- begin item 7b3039a9-20a4-42cc-a500-c6c8fdbc3697 --><!-- begin field f659a121-0e3b-4d87-8de3-154fb0cf13fe --><p>The recommendations on how to assess a person with suspected hypothyroidism are largely based on the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Thyroid disease: assessment and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">NICE, 2019</a>], the joint UK publication <em>UK guidelines for the use of thyroid function tests</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Association for Clinical Biochemisty, 2006</a>], the British Thyroid Association (BTA) publication <em>Management of primary hypothyroidism</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Okosieme, 2015</a>]; the European Thyroid Association (ETA) guidelines <em>The use of L-T4 + L-T3 in the treatment of hypothyroidism </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Wiersinga et al, 2012</a>], <em>Management of subclinical hypothyroidism</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Pearce, 2013</a>], <em>Guidelines for the management of subclinical hypothyroidism in pregnancy and in children</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Lazarus et al, 2014</a>], and <em>Guidelines on the diagnosis and management of central hypothyroidism</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Persani, 2018</a>]; the Endocrine Society clinical practice guideline <em>Management of thyroid dysfunction during pregnancy and postpartum</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">De Groot et al, 2012</a>]; the American Thyroid Association (ATA) publication <em>Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Alexander, 2017</a>], expert opinion in review articles on hypothyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Chaker, 2017</a>], treatment-refractory hypothyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">McNally, 2019</a>], and subclinical hypothyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Cooper and Biondi, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Peeters, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Biondi, 2019</a>], and expert opinion in a medical textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Weetman, 2010</a>].</p><h4>Clinical features on history-taking</h4><ul><li>The recommendation not to check thyroid function tests (TFTs) during an acute non-thyroidal illness and to wait until this has resolved is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">NICE, 2019</a>], the ETA guideline on subclinical hypothyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Pearce, 2013</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Peeters, 2017</a>].</li><li>The recommendation to check for risk factors for hypothyroidism is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">NICE, 2019</a>], the joint UK publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Association for Clinical Biochemisty, 2006</a>], the ETA publications on combination therapy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Wiersinga et al, 2012</a>] and subclinical hypothyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Pearce, 2013</a>], and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Cooper and Biondi, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Chaker, 2017</a>] and a medical textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Weetman, 2010</a>].</li></ul><h4>Clinical features on examination</h4><ul><li>The recommendations on examination findings are based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Chaker, 2017</a>].</li></ul><h4>Interpretation of TFT results</h4><ul><li>The recommendation to check the serum TSH level first and then the free thyroxine (FT4) level if TSH is raised in people with suspected primary hypothyroidism, is based on the experience and expertise of the NICE guideline development group, with the aim to reduce unnecessary testing [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">NICE, 2019</a>].</li><li>The recommendation to consider arranging repeat TFTs depending on clinical judgement is based on the fact there is biological variation in TSH levels, which may rise with stress and transient non-thyroidal illness for example, so one abnormal TSH level should be followed by a repeat blood test to confirm the diagnosis of hypothyroidism or subclinical hypothyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Weetman, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Pearce, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Chaker, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Peeters, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Persani, 2018</a>].<ul><li>CKS notes that the NICE clinical guideline does not recommend re-testing TSH levels routinely, but to arrange re-testing if initial results are euthyroid in the presence of worsening or new symptoms. NICE recommends waiting at least six weeks before re-testing TFTs, as repeating tests sooner is unlikely to provide any new information [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">NICE, 2019</a>]. </li></ul></li><li>The recommendation on diagnosing primary hypothyroidism is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">NICE, 2019</a>], the joint UK publication on TFTs [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Association for Clinical Biochemisty, 2006</a>], and the BTA publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Okosieme, 2015</a>].</li><li>The recommendation on diagnosing subclinical hypothyroidism is based on the joint UK publication on TFTs [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Association for Clinical Biochemisty, 2006</a>], the ETA guideline on subclinical hypothyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Pearce, 2013</a>], and the BTA publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Okosieme, 2015</a>].</li><li>The recommendation on diagnosing hypothyroidism in pregnancy using trimester-specific reference ranges is based on the ETA guideline on subclinical hypothyroidism in pregnancy and children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Lazarus et al, 2014</a>] and the ATA guidelines on pregnancy and the postpartum [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Alexander, 2017</a>].</li><li>The recommendation to check both serum TSH and FT4 levels on initial blood testing in people with suspected secondary hypothyroidism is based on the fact the TSH level may be inappropriately low or normal [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">NICE, 2019</a>]. The information on the TFT results suggesting a diagnosis of central hypothyroidism is based on the joint UK publication on TFTs [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Association for Clinical Biochemisty, 2006</a>] and the ETA guidelines on central hypothyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Persani, 2018</a>].</li><li>The recommendation not to routinely measure total tri-iodothyronine (T3), total thyroxine (T4), or free tri-iodothyronine (FT3) levels in primary care is based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Chaker, 2017</a>].</li></ul><h4>Checking additional blood tests for associated conditions</h4><ul><li>The recommendations to check a full blood count (FBC) and B12 level to assess for possible associated pernicious anaemia, and HbA1c to assess for diabetes mellitus, are based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">McNally, 2019</a>] and are extrapolated from the NICE clinical guideline on type 1 diabetes, which notes that other autoimmune conditions may develop in people with type 1 diabetes, including pernicious anaemia and thyroid disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">NICE, 2015a</a>].</li><li>The recommendation to check coeliac serology if a diagnosis of autoimmune thyroid disease is suspected is based on the NICE clinical guideline on coeliac disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">NICE, 2015b</a>].</li><li>The recommendation to check serum lipids is based on the fact hypothyroidism is a known secondary cause of increased heart disease risk and dyslipidaemia, as outlined in the NICE clinical guideline on cardiovascular disease and lipid modification [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">NICE, 2016</a>].</li></ul><h4>Checking serum thyroid peroxidase antibodies (TPOAbs)</h4><ul><li>The recommendation to check TPOAbs if the TSH level is raised in adults with suspected primary hypothyroidism or subclinical hypothyroidism, is based on the experience and expertise of the NICE guideline development group [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">NICE, 2019</a>] and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Chaker, 2017</a>].<ul><li>NICE advised not to repeat TPOAb testing, as changes in levels are unlikely to guide treatment decisions.</li><li>In cases of subclinical hypothyroidism, the presence of positive TPOAbs can guide more frequent checking of TFTs if it is untreated or levothyroxine (LT4) therapy has been stopped [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">NICE, 2019</a>].</li><li>Raised TPOAb levels suggest a diagnosis of primary autoimmune hypothyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Chaker, 2017</a>].</li></ul></li><li>This approach is supported by the ETA guideline on subclinical hypothyroidism, which recommends checking TPOAbs if subclinical hypothyroidism is suspected following initial blood tests [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Pearce, 2013</a>]. This is in line with expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Peeters, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Biondi, 2019</a>].<ul><li>The presence of positive autoantibodies suggests that autoimmune thyroiditis is the cause [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Pearce, 2013</a>].</li><li>Repeated antibody measurements do not enhance the monitoring of people with subclinical hypothyroidism [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Pearce, 2013</a>].</li><li>If a person has positive TPOAbs, they are twice as likely to progress from a diagnosis of subclinical hypothyroidism to overt hypothyroidism as people without antibodies [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Pearce, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Peeters, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Biondi, 2019</a>].</li></ul></li><li>The recommendation to check TPOAbs in pregnancy is based on the ATA guidelines on pregnancy and the postpartum [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Alexander, 2017</a>], the ETA guidelines on subclinical hypothyroidism in pregnancy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Lazarus et al, 2014</a>], and the Endocrine Society clinical practice guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">De Groot et al, 2012</a>].<ul><li>The ATA guidelines note that thyroid antibody positivity separately increases the risk of thyroid dysfunction following delivery and during the postpartum period. Women who are TPOAb positive in the first trimester have a high risk of developing postpartum thyroiditis. There is a greater risk for adverse events in women who are TPOAb positive compared to those who are TPOAb negative, even when thyroid function is identical. Specialist decisions about LT4 treatment must be based on both measurement of thyroid function and TPOAb status [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Alexander, 2017</a>].</li><li>The ETA guidelines note that thyroid autoantibodies are detected in about 50% of pregnant women with subclinical hypothyroidism and in more than 80% with overt hypothyroidism. Measurement of TPOAbs gives an indication of thyroid autoimmunity [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Lazarus et al, 2014</a>].</li><li>TPOAb positivity is the most useful marker for the prediction of postpartum thyroid dysfunction. Women with elevated TPOAbs are at increased risk for miscarriage, preterm delivery, progression of hypothyroidism, and postpartum thyroiditis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">De Groot et al, 2012</a>].</li><li>The information that after the first trimester, TPOAbs may be negative due to the immune suppression in pregnancy is based on the ETA guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">Lazarus et al, 2014</a>].</li></ul></li></ul><h4>Arranging a neck ultrasound scan</h4><ul><li>The recommendation on when to arrange an ultrasound of the neck is based on the NICE clinical guideline on thyroid disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hypothyroidism/references/\">NICE, 2019</a>].</li></ul><!-- end field f659a121-0e3b-4d87-8de3-154fb0cf13fe --><!-- end item 7b3039a9-20a4-42cc-a500-c6c8fdbc3697 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}